Breaking News

Thermo Fisher, Symphogen Extend Development Pact

Will support the development of cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific and Symphogen, an affiliate of Servier, have extended a strategic collaboration to deliver innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development. Since the collaboration was established in 2018, Symphogen has been using the analytical capabilities of the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters